<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate quantitative or qualitative differences in synovial fluid (SF) cytokine levels among patients with systemic <z:hpo ids='HP_0005681'>juvenile rheumatoid arthritis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e>), <z:hpo ids='HP_0003493'>antinuclear antibody positive</z:hpo> <z:e sem="disease" ids="C0157917" disease_type="Disease or Syndrome" abbrv="">pauciarticular JRA</z:e>, or adult RA </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: SF levels of interleukin 1alpha (IL-1alpha), IL-1beta, IL-1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (IL-1Ra) IL-11, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha), soluble TNF receptor 1 (sTNFR1), <z:hpo ids='HP_0001909'>leukemia</z:hpo> inhibitory factor (LIF), <z:hpo ids='HP_0000001'>all</z:hpo> measured by immunoassays, and of IL-6, measured with a bioassay using B9 cells, were evaluated in 11 patients with systemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e>, 24 with <z:e sem="disease" ids="C0157917" disease_type="Disease or Syndrome" abbrv="">pauciarticular JRA</z:e>, and 22 adult patients with RA </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: SF IL-6 levels were significantly higher in patients with systemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> than patients with <z:e sem="disease" ids="C0157917" disease_type="Disease or Syndrome" abbrv="">pauciarticular JRA</z:e> (p = 0.003) or RA (p = 0.002) </plain></SENT>
<SENT sid="3" pm="."><plain>IL-1alpha was detectable in 12/24 SF samples from <z:e sem="disease" ids="C0157917" disease_type="Disease or Syndrome" abbrv="">pauciarticular JRA</z:e>, in 2/22 SF from RA, and in no sample from systemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> (p = 0.004 vs RA; p = 0.005 vs systemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>SF IL-11 levels were significantly higher in patients with RA than patients with systemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> (p = 0.012) or <z:e sem="disease" ids="C0157917" disease_type="Disease or Syndrome" abbrv="">pauciarticular JRA</z:e> (p = 0.005) </plain></SENT>
<SENT sid="5" pm="."><plain>We found no significant differences in SF levels of IL-1beta, IL-1Ra, TNF-alpha, sTNFR1, or LIF </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: In systemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e>, SF levels of IL-6 are significantly higher than in <z:e sem="disease" ids="C0157917" disease_type="Disease or Syndrome" abbrv="">pauciarticular JRA</z:e> or in RA; IL-1alpha is present in a significant proportion of patients with <z:e sem="disease" ids="C0157917" disease_type="Disease or Syndrome" abbrv="">pauciarticular JRA</z:e>, but not in those with RA or systemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> </plain></SENT>
</text></document>